Search Results - "glucagon"

The Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS by Aleksandra Jaroń, Agata Wiklińska, Katarzyna Jastrzębska, Maria Witkowska, Joanna Skotnicka, Karolina Błaszczak, Monika Turek, Klara Wojciechowska, Adrian Borkowski, Mateusz Sawicki

Connect to this object online.

Injections for weight loss: what's new in GLP-1 RAs for obesity treatment - review by Małgorzata Maria Zając, Radosław Zaucha, Julia Silldorff, Stanisław Anczyk, Marcin Dudek, Tomasz Fura, Zuzanna Felińska, Oliwia Iszczuk, Magdalena Gajkiewicz, Magdalena Jaskółka

Connect to this object online.

Evaluating the bioequivalence and safety of liraglutide injection versus Victoza® in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial by Chao Liu, Hongrong Xu, Fei Yuan, Hanjing Chen, Lei Sheng, Weili Chen, Haisong Xie, Hongmei Xu, Xuening Li

Connect to this object online.

GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress by Yaojing Jiang, Zhihong Wang, Bo Ma, Linling Fan, Na Yi, Bin Lu, Qinghua Wang, Qinghua Wang, Rui Liu

Connect to this object online.

Fructo-oligosaccharides alleviate inflammation-associated apoptosis of GLP-1 secreting L cells via inhibition of iNOS and cleaved caspase-3 expression by Preedajit Wongkrasant, Pawin Pongkorpsakol, Sasirin Chitwattananont, Wilasinee Satianrapapong, Nuttha Tuangkijkul, Chatchai Muanprasat

Connect to this object online.

A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus by Belete TM

Connect to this object online.

Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists by Veronika A. Myasoedova, Michele Bozzi, Vincenza Valerio, Donato Moschetta, Ilaria Massaiu, Valentina Rusconi, Daniele Di Napoli, Michele Ciccarelli, Valentina Parisi, Piergiuseppe Agostoni, Stefano Genovese, Paolo Poggio

Connect to this object online.

Liraglutide for weight management: a critical review of the evidence by A. Mehta, S. P. Marso, I. J. Neeland

Connect to this object online.

Tirzepatide for type 2 diabetes by Sarah L Anderson, Joel C Marrs

Connect to this object online.

Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection by Maribel Beaumont, Daniela Tomazela, Douglas Hodges, Grigori Ermakov, Edward Hsieh, Isabel Figueroa, On-Yee So, Yaoli Song, Huiping Ma, Svetlana Antonenko, Wondwessen Mengesha, Yi Wei Zhang, Shuli Zhang, SuChun Hseih, Gulesi Ayanoglu, Xiaoyan Du, Eric Rimmer, Michael Judo, Franklin Vives, Jennifer H. Yearley, Christina Moon, Anthony Manibusan, Nick Knudsen, Andy Beck, Damien Bresson, Dennis Gately, Divas Neupane, Enrique Escandón

Connect to this object online.

Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway by Makoto Shigeto, Masashi Katsura, Masafumi Matsuda, Seitaro Ohkuma, Kohei Kaku

Connect to this object online.

Insulin resistance prior to term age in very low birthweight infants: a prospective study by Magnus Domellöf, Itay Zamir, Elisabeth Stoltz Sjöström, Estelle Naumburg, Johannes van den Berg

Connect to this object online.

Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes by Zhang Y, Chen R, Jia Y, Chen M, Shuai Z

Connect to this object online.

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers by Gu N, Park MK, Kim TE, Bahng MY, Lim KS, Cho SH, Yoon SH, Cho JY, Jang IJ, Yu KS

Connect to this object online.

Acute generalized exanthematous pustulosis sine pustules following semaglutide injection by Nayha P. Shetty, MD, Jesse Veenstra, MD, PhD

Connect to this object online.

Semaglutide-associated bullous pemphigoid by Clayton P. Burruss, BS, Jordan M. Jones, MD, Jyoti B. Burruss, MD

Connect to this object online.

GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes by Shivani Srivastava, Harsh Pandey, Surya Kumar Singh, Yamini Bhusan Tripathi

Connect to this object online.

Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its Subcutaneous Injection in Rats by Jeferson Ziebarth, Letícia Marina da Silva, Ariane Krause Padilha Lorenzett, Ingrid Delbone Figueiredo, Paulo Fernando Carlstrom, Felipe Nunes Cardoso, André Luiz Ferreira de Freitas, Amanda Martins Baviera, Rubiana Mara Mainardes

Connect to this object online.

Anti-diabetic Agents and the Potentials for Reducing Cardiovascular Risks in Type-2 Diabetes Mellitus by Ezeani IU, Eregie A, Ohwovoriole AE

Connect to this object online.

Therapeutic Potential of MgO and MnO Nanoparticles Within the Context of Thyroid Profile and Pancreatic Histology in a Diabetic Rat Model by Arslan Shaukat, Ghulam Hussain, Shahzad Irfan, Muhammad Umar Ijaz, Haseeb Anwar

Connect to this object online.